Trillium Asset Management’s Edwards Lifesciences EW Stock Holding History

Trillium Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-94,694	Closed	-$7.01M	–	229
2024 Q4	$7.01M	Sell	94,694 -9,333	-9%	-$653K	0.18%	121
2024 Q3	$6.87M	Sell	104,027 -4,185	-4%	-$304K	0.17%	128
2024 Q2	$10M	Sell	108,212 -2,549	-2%	-$226K	0.25%	95
2024 Q1	$10.6M	Buy	110,761 +519	+0.5%	+$43.6K	0.27%	93
2023 Q4	$8.41M	Sell	110,242 -1,615	-1%	-$112K	0.23%	101
2023 Q3	$7.75M	Sell	111,857 -2,614	-2%	-$210K	0.23%	99
2023 Q2	$10.8M	Buy	114,471 +2,365	+2%	+$206K	0.3%	94
2023 Q1	$9.86M	Buy	112,106 +31,488	+39%	+$2.48M	0.29%	89
2022 Q4	$6.01M	Sell	80,618 -3,765	-4%	-$290K	0.19%	110
2022 Q3	$6.97M	Sell	84,383 -1,005	-1%	-$96.7K	0.23%	101
2022 Q2	$8.12M	Hold	85,388	–	–	0.25%	96
2022 Q1	$10.1M	Sell	85,388 -202	-0.2%	-$22.7K	0.27%	94
2021 Q4	$11.1M	Buy	85,590 +1,420	+2%	+$166K	0.26%	98
2021 Q3	$9.53M	Buy	84,170 +4,030	+5%	+$460K	0.25%	100
2021 Q2	$8.3M	Buy	80,140 +2,513	+3%	+$237K	0.23%	103
2021 Q1	$6.49M	Hold	77,627	–	–	0.21%	107
2020 Q4	$7.08M	Buy	77,627 +499	+0.6%	+$41.4K	0.25%	98
2020 Q3	$6.16M	Buy	77,128 +707	+0.9%	+$55.2K	0.26%	98
2020 Q2	$5.28M	Sell	76,421 -640	-0.8%	-$45.5K	0.23%	100
2020 Q1	$4.84M	Hold	77,061	–	–	0.26%	103
2019 Q4	$5.99M	Sell	77,061 -1,614	-2%	-$126K	0.27%	109
2019 Q3	$5.77M	Buy	78,675 +1,512	+2%	+$106K	0.27%	110
2019 Q2	$4.75M	Hold	77,163	–	–	0.23%	116
2019 Q1	$4.92M	Hold	77,163	–	–	0.25%	114
2018 Q4	$3.94M	Sell	77,163 -369	-0.5%	-$18.7K	0.23%	119
2018 Q3	$4.5M	Hold	77,532	–	–	0.23%	120
2018 Q2	$3.76M	Hold	77,532	–	–	0.2%	127
2018 Q1	$3.61M	Sell	77,532 -9,000	-10%	-$391K	0.2%	127
2017 Q4	$3.25M	Sell	86,532 -25,644	-23%	-$941K	0.18%	134
2017 Q3	$4.09M	Buy	112,176 +2,400	+2%	+$91.5K	0.23%	118
2017 Q2	$4.33M	Hold	109,776	–	–	0.26%	117
2017 Q1	$3.44M	Buy	+109,776	New	+$3.44M	0.22%	120